focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insur Regulatory News (SBRE)

Share Price Information for Sabre Insur (SBRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 162.20
Bid: 161.00
Ask: 161.80
Change: 1.20 (0.75%)
Spread: 0.80 (0.497%)
Open: 161.00
High: 162.20
Low: 160.80
Prev. Close: 161.00
SBRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

31 Mar 2023 15:37

RNS Number : 0061V
Sabre Insurance Group PLC
31 March 2023
 

31 March 2023

 

Sabre Insurance Group plc ("Sabre" or the "Company")

Notification of transactions of Directors, Persons Discharging Managerial Responsibility ("PDMRs") or Connected Persons

 

Sabre announces that the following transactions were undertaken by Directors and PDMRs in the ordinary shares of the Company on 30 March 2023, in connection with the maturity of the awards granted in 2021 under Sabre's 2017 Deferred Bonus Plan ("DBP").

 

Each Director or PDMR deferred half of their annual bonus from the financial year ended 31 December 2020 into the DBP. The deferred bonus was used to purchase shares in the Company at a price of 241.5 pence per share ("DBP award shares"), which were then held in the Employee Benefit Trust for a two-year deferral period. No performance conditions are attached to the DBP award shares.

 

Further information on the DBP grant can be found in the Company's Annual Report, which is available on the Company's website www.sabreplc.co.uk 

 

Details of the transactions following the DBP's vesting are as follows:

Name and Job Title

Number of shares vested

Number of shares sold

Price at Vesting and Sale

(p)

Number of shares held in the Company post the transaction

Sabre shareholding as a % of issued share capital

Geoff Carter

Chief Executive Officer

69,610

33,587

111.540

1,645,340

0.65%

Anneka Kingan

Chief Risk Officer and Company Secretary

34,083

16,378

111.540

37,342

0.01%

Trevor Webb Claims Director

53,231

0*

n/a

1,304,568

0.52%

Adam Westwood Chief Financial Officer

40,947

40,947

111.540

686,267

0.28%

Matt Wright

Chief Actuary

8,094

8,094

111.540

250,000

0.10%

 

* Mr Webb did not sell any shares and settled the tax liability which arose from the award's vesting, directly with the Company.

 

This notification is made pursuant to Article 19 of the EU Market Abuse Regulation.

 

Additional Information:

Anneka Kingan - Company Secretary

Anneka.kingan@sabre.co.uk

LEI Code: 2138006RXRQ8P8VKGV98

 

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Geoff Carter

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group Plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of £0.001 each

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Vesting and sale of awards to cover tax, under the Company's Deferred Bonus Plan

c)

 

Price(s) and volume(s)

 Price per share

Volume

£0

69,610

£1.1154

33,587

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

69,610

£0

33,587

£1.1154

 

e)

Date of transaction

30 March 2023

f)

Place of transaction

London Stock Exchange (XLON)

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Anneka Kingan

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Risk Officer and Company Secretary

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group Plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of £0.001 each

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Vesting and sale of awards to cover tax, under the Company's Deferred Bonus Plan

 

c)

 

Price(s) and volume(s)

 

Price per share

Volume

£0

34,083

£1.1154

16,378

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

34,083

£0

16,378

£1.1154

 

e)

Date of transaction

30 March 2023

f)

Place of transaction

London Stock Exchange (XLON)

 

 

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Trevor Webb

2

 

Reason for the notification

 

a)

 

Position/status

 

Claims Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group Plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of £0.001 each

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Vesting of awards under the Company's Deferred Bonus Plan

c)

 

Price(s) and volume(s)

 

Price per share

Volume

£0

53,231

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

53,231

£0

 

e)

Date of transaction

30 March 2023

f)

Place of transaction

London Stock Exchange (XLON)

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Adam Westwood

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group Plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of £0.001 each

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Vesting and sale of awards under the Company's Deferred Bonus Plan

c)

 

Price(s) and volume(s)

 

Price per share

Volume

£1.1154

40,947

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

40,947

£1.1154

 

e)

Date of transaction

30 March 2023

f)

Place of transaction

London Stock Exchange (XLON)

 

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Matt Wright

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Actuary

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group Plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of £0.001 each

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Vesting and sale of awards under the Company's Deferred Bonus Plan

c)

 

Price(s) and volume(s)

 

Price per share

Volume

£1.1154

8,094

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

8,094

£1.1154

 

e)

Date of transaction

30 March 2023

f)

Place of transaction

London Stock Exchange (XLON)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHZFLFXXXLXBBE
Date   Source Headline
21st Feb 202212:31 pmRNSHolding(s) in Company
11th Feb 202211:34 amRNSDirector/PDMR Shareholding
28th Jan 20227:00 amRNSNew Contract with Freeway Insurance Services Ltd
11th Jan 20222:27 pmRNSDirector/PDMR Shareholding
13th Dec 20211:37 pmRNSDirector/PDMR Shareholding
9th Dec 20217:00 amRNSAppointment of new additional broker
29th Nov 20217:00 amRNSDirectorate Change
11th Nov 20211:20 pmRNSDirector/PDMR Shareholding
10th Nov 20217:00 amRNSNew Contract as Exclusive Underwriter to MCE
5th Nov 202111:58 amRNSDirector/PDMR Shareholding
14th Oct 20212:27 pmRNSDirector/PDMR Shareholding
14th Oct 202111:41 amRNSDirector/PDMR Shareholding
14th Oct 20217:00 amRNSQ3 Trading Update
12th Oct 202112:06 pmRNSDirector/PDMR Shareholding
12th Oct 202112:02 pmRNSDirector Declaration
7th Oct 20217:00 amRNSNotice of Trading Update
17th Sep 20212:34 pmRNSDirector/PDMR Shareholding
17th Sep 20212:33 pmRNSDirector/PDMR Shareholding
13th Sep 202111:55 amRNSDirector/PDMR Shareholding
11th Aug 20219:51 amRNSDirector/PDMR Shareholding
30th Jul 202110:15 amRNSDirector/PDMR Shareholding
28th Jul 20213:14 pmRNSDirector/PDMR Shareholding
27th Jul 20217:00 amRNSHalf-year Report
13th Jul 202111:24 amRNSDirector/PDMR Shareholding
13th Jul 20217:00 amRNSNotice of Results
6th Jul 202111:00 amRNSHolding(s) in Company
2nd Jul 202112:50 pmRNSDirector/PDMR Shareholding
29th Jun 202111:39 amRNSHolding(s) in Company
22nd Jun 20213:46 pmRNSHolding(s) in Company
11th Jun 202110:53 amRNSDirector/PDMR Shareholding
21st May 20212:28 pmRNSDirector/PDMR Shareholding
21st May 20212:05 pmRNSDirector/PDMR Shareholding
21st May 202110:34 amRNSDirector/PDMR Shareholding
19th May 202112:49 pmRNSHolding(s) in Company
14th May 202111:46 amRNSResults of Annual General Meeting
14th May 20217:00 amRNSTrading Statement
11th May 20211:20 pmRNSDirector/PDMR Shareholding
22nd Apr 202110:00 amRNSDirector/PDMR Shareholding Replacement
22nd Apr 20219:51 amRNSDirector/PDMR Shareholding
14th Apr 20219:01 amRNSDirector/PDMR Shareholding
13th Apr 202111:12 amRNSDirector/PDMR Shareholding
12th Apr 20214:41 pmRNSNotice of AGM
7th Apr 20212:16 pmRNSDirector/PDMR Shareholding
30th Mar 20211:56 pmRNSDirector/PDMR Shareholding
26th Mar 20218:24 amRNSDirector/PDMR Shareholding
16th Mar 20217:03 amRNSFinal Results
12th Mar 20217:00 amRNSNotice of Results
11th Mar 202110:37 amRNSDirector/PDMR Shareholding
1st Mar 20213:56 pmRNSHolding(s) in Company
23rd Feb 202110:40 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.